patent

Newgen Software Granted Indian Patent for Groundbreaking Data Compression Innovation

by

Newgen Software Technologies Ltd., a global leader in digital transformation solutions, has secured a significant milestone with the grant of a new patent by the Indian Patent Office. The patent, titled “System and Method for Data Compression” (Patent No. 565385), has been awarded for a 20-year term beginning April 26, 2017, under the provisions of the Indian Patents Act, 1970.

This latest patent highlights Newgen’s commitment to continuous innovation in the field of enterprise software and data management. The patented system introduces a novel approach to data compression, specifically designed to efficiently manage large volumes of files that contain mostly repetitive content with only small portions of variable data. Such data patterns are common in sectors like finance, healthcare, and government operations where document generation is highly templated.

Addressing Limitations of Traditional Techniques

Traditional data compression algorithms often struggle with files that, while large, differ only slightly from one another. These conventional methods may fail to deliver meaningful storage reductions or may compromise processing speed in such use cases. Newgen’s patented solution seeks to overcome these challenges by employing a more intelligent and adaptive method that focuses on identifying and compressing recurring content while effectively managing the dynamic parts of the data.

According to Newgen, the invention not only enhances compression ratios but also boosts the overall performance of data handling systems. By significantly reducing storage requirements and improving the efficiency of data transmission and retrieval, the technology has the potential to deliver substantial cost and resource savings for organizations managing extensive digital archives.

A Step Forward in Enterprise Efficiency

Speaking on the development, a Newgen spokesperson stated, “This patent is a testament to our continuous efforts to push the boundaries of enterprise innovation. Efficient data compression is critical in today’s digital landscape where businesses deal with massive volumes of structured and unstructured information. Our solution provides a smarter alternative to conventional techniques and can be a game-changer for industries dealing with high-volume, low-variance data.”

Newgen Software has a strong track record of investing in research and development, with a growing portfolio of patents that span process automation, document management, and AI-driven analytics. The newly patented data compression system is expected to be integrated into its existing platforms and may also be offered as a standalone solution for enterprises looking to optimize their data infrastructure.

About Newgen Software

Headquartered in New Delhi, Newgen Software is a global provider of low-code digital automation platforms that drive smarter processes and simpler customer journeys. The company’s solutions are widely used across banking, insurance, healthcare, government, and other sectors to automate complex business processes and enhance digital experiences.

Chandigarh Students Secure Patent for ‘GestureX’ – Revolutionary Smart Glasses that Translate Speech into Sign Language

by

In a breakthrough moment for accessible technology in India, a team of students from Chandigarh has been awarded a design patent for their innovative invention – GestureX, a pair of smart glasses that can convert spoken language into sign language in real-time. This pioneering project aims to bridge communication gaps for the hearing-impaired, enhancing inclusivity in education, workplaces, and daily life.

Breaking Communication Barriers with Technology
GestureX represents a significant leap in assistive wearable technology. The device is expected to transform how individuals with hearing disabilities interact with the world around them, particularly in environments where sign language interpreters are unavailable.

The patent, granted under Class 16-06 (relating to communication equipment), marks formal recognition of the students’ innovation, positioning GestureX as a potential game-changer in inclusive communication tools.

How GestureX Works
The functionality of GestureX is underpinned by a combination of hardware and software components that work seamlessly together:

Built-in Microphones: The glasses are fitted with directional microphones that capture ambient speech in real-time.

Speech Recognition Engine: Advanced software processes spoken words and converts them into text-based commands.

Sign Language Renderer: A miniature display system integrated into the glasses projects animated sign language gestures that correspond to the recognized speech.

Efficient Power Management: Designed with lightweight battery systems, GestureX ensures portability and extended battery life for regular use.

The glasses have been optimized to recognize multiple accents and background noise, ensuring accuracy in varied environments like classrooms, conferences, or public transport.

Designed by Students, Backed by Innovation
The team behind GestureX comprises students from diverse technical backgrounds who came together with a shared vision to make technology more inclusive. Motivated by personal experiences and community challenges, the team sought to develop a tool that could empower the deaf and hard-of-hearing communities with greater independence and confidence.

According to the team spokesperson, “Our goal was to build something meaningful that could help real people in real situations. GestureX is not just a gadget—it’s a step toward equal access and inclusive communication.”

Broader Implications and Future Development
GestureX’s creators are in discussions with academic institutions and healthcare providers to initiate pilot testing of the device. Early trials will help refine the technology, particularly for use in multilingual settings where regional sign language variants are common.

Looking ahead, the team plans to integrate artificial intelligence to allow the glasses to adapt to individual speech patterns, improve gesture accuracy, and potentially support reverse translation—from sign language to spoken words—to facilitate two-way communication.

They are also exploring partnerships for manufacturing and scaling the product, with the aim of keeping it affordable for individuals and organizations that serve the deaf and hard-of-hearing communities.

A Leap Forward in Assistive Tech
As India continues to promote inclusive innovation through programs like Startup India and the Atal Innovation Mission, projects like GestureX highlight the role of youth-led innovation in solving socially relevant problems. The device stands as a testament to the power of interdisciplinary collaboration and the potential for accessible design to foster greater equity in communication.

If successfully commercialized, GestureX could join the ranks of transformative assistive devices, not only within India but globally, providing a much-needed communication bridge in an increasingly interconnected world.

University of Hyderabad Researchers Secure Patents for Pioneering Innovations in Materials Science

by
The University of Hyderabad (UoH), one of India’s premier research institutions, continues to solidify its reputation in scientific innovation, with two newly granted patents in the field of materials science and microwave technology.

The patents, awarded to faculty members from the School of Physics and the Advanced Centre of Research in High Energy Materials (ACRHEM), underscore UoH’s growing impact in high-performance materials research with wide-ranging industrial applications.

Innovation in 3D Ceramic Resonators
The first patent, titled “Dielectric Resonators with Complex 3D Geometries Using Gel Casting Techniques,” is credited to Professors K.C. James Raju and V. Seshubai, along with research scholars T. Anil and Swarup Raju. This novel method facilitates the production of high-temperature ceramic dielectric resonators molded into intricate three-dimensional structures.

Traditionally, creating 3D resonators from ceramic materials poses significant challenges due to their brittle nature and high processing temperatures. The patented gel casting approach overcomes these limitations, enabling the fabrication of compact and high-performance resonators suitable for next-generation microwave and millimeter-wave communication systems.

“This technique opens new pathways for designing miniaturized antennas and frequency filters, particularly in 5G and satellite communication devices,” explained Prof. Raju.

Breakthrough in Low-Temperature Crystallization
The second patent focuses on the laser-based crystallization of ferroelectric thin films, a breakthrough that significantly lowers the thermal requirements for these critical materials. Spearheaded again by Prof. K.C. James Raju and his team, the technique successfully reduces the crystallization temperature from 700°C to 300°C by utilizing controlled laser irradiation.

This innovation has significant implications for the electronics industry, particularly in the integration of ferroelectric materials into semiconductor devices, which typically cannot endure high processing temperatures. Lower thermal thresholds enable the application of these films in tunable microwave components, sensors, and energy-efficient electronic devices.

“This development bridges the gap between high-performance ferroelectric materials and practical device manufacturing,” noted Prof. Raju.

UoH’s Growing Patent Portfolio
With these two patents, the University of Hyderabad continues to expand its footprint in applied scientific research and industrial collaboration. The institution has increasingly focused on promoting innovation that addresses real-world challenges in communication, electronics, and advanced materials.

Vice-Chancellor Prof. B.J. Rao praised the research teams for their work, stating, “These achievements are a testament to the University’s commitment to fostering a research environment that supports both theoretical advancement and practical application.”

Looking Ahead
As global industries seek cost-effective and scalable technologies in electronics and telecommunications, the breakthroughs from UoH researchers could play a pivotal role in shaping future solutions. The university also aims to collaborate with industries and startups to bring these patented technologies from the lab to the market.

While the university has yet to announce any patent specifically related to alpha alumina platelets, these recent innovations indicate that UoH remains a leader in cutting-edge materials science research with broad commercial potential.

Donald Trump Urged to Target ‘Lazy Patent Expansion’ in U.S. Drug Bill Push

by
In a significant development in the ongoing debate over U.S. drug pricing, Richard Saynor, CEO of Sandoz, a leading generic pharmaceutical company, has called on former President Donald Trump to address the issue of “lazy patent expansion” in his efforts to reduce prescription drug costs. Saynor’s remarks come as Trump seeks to implement a “most favored nation” policy, aiming to align U.S. drug prices of other nations. While supporting this initiative, Saynor emphasized the need for reform in the generics market to ensure sustainable access to affordable medications.

The Problem: Patent Thickets and Evergreening
Saynor criticized the practice of “evergreening,” where brand-name drug manufacturers file numerous patents on slight modifications of existing drugs to extend their market exclusivity. This strategy, often referred to as creating “patent thickets,” has been used to delay the entry of generic competitors, thereby maintaining high drug prices. For instance, blockbuster drugs like AbbVie’s Humira have been subject to extensive patent filings, with over 140 patents filed per top-selling drug, causing prices to remain high and limiting competition.

Impact on Generic Drug Market
Generic drugs account for approximately 90% of prescriptions in the U.S. and are significantly more affordable than their branded counterparts. However, the proliferation of patent thickets has led to shortages and limited availability of generics. Saynor highlighted that the rebate system, which involves pharmacy benefit managers, further inflates drug costs, making it more challenging for generics to compete.

Proposed Solutions
To address these issues, Saynor advocated for reinstating a six-month exclusivity period for first-to-market generics, a policy that could incentivize the development and availability of affordable alternatives. Additionally, he cautioned against proposed pharmaceutical tariffs, which could disproportionately impact generics due to their low margins and reliance on overseas production.

Legislative Efforts and Challenges
Bipartisan efforts to reform the patent system have been introduced in Congress, targeting practices like patent thickets, product hopping, and pay-for-delay agreements. Despite strong support, these bills have faced obstacles in becoming law, often due to legislative gridlock and opposition from industry stakeholders.

Global Implications
Trump’s “most favored nation” policy, which seeks to align U.S. drug prices with those paid by other countries, has raised concerns internationally. In the UK, for example, where branded drugs cost significantly less than in the U.S., pharmaceutical firms may respond by raising prices elsewhere or withholding drugs from certain markets. This could strain healthcare systems globally and potentially discourage pharmaceutical innovation.

Conclusion
As the U.S. continues to grapple with high drug prices, addressing the issue of “lazy patent expansion” is crucial for fostering a competitive and affordable pharmaceutical market. While Trump’s policy initiatives aim to reduce costs, comprehensive reform of the patent system is necessary to ensure long-term access to essential medications for all Americans.

Biofrontera Inc. Secures Extended Patent Protection for Ameluz® and Completes Patient Enrollment in Phase 2b Acne Study

by

Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in dermatological treatments, has announced two significant milestones: the extension of U.S. patent protection for its flagship product, Ameluz® (aminolevulinic acid hydrochloride) topical gel, 10%, and the completion of patient enrollment in its Phase 2b clinical trial evaluating Ameluz® for the treatment of moderate to severe acne vulgaris.

Extended Patent Protection for Ameluz®

The U.S. Patent and Trademark Office (USPTO) has granted Biofrontera a new patent related to a photodynamic therapy (PDT) protocol that is expected to be less painful while maintaining efficacy. This patent extends the protection of Ameluz®-PDT through October 2040. Further patents are pending, which may extend protection until 2043 or beyond. 

This extension fortifies Biofrontera’s intellectual property portfolio, ensuring prolonged market exclusivity for Ameluz® and its associated PDT protocols. The company anticipates that this will bolster its competitive position in the dermatological therapeutics market.

Completion of Phase 2b Acne Study Enrollment

In parallel, Biofrontera has successfully completed patient enrollment in its Phase 2b clinical trial assessing the efficacy and safety of Ameluz® for treating moderate to severe acne vulgaris.  This randomized, double-blind study aims to explore the potential of Ameluz® as a novel PDT option for acne, a condition affecting millions worldwide.

The trial’s completion of enrollment marks a significant step toward expanding the indications for Ameluz®.  Pending positive outcomes, Biofrontera plans to advance to Phase 3 trials, with the goal of submitting a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2026. 

Strategic Outlook

These developments underscore Biofrontera’s commitment to innovation in dermatological therapies.  By securing extended patent protection and advancing clinical research, the company aims to enhance its product offerings and address unmet needs in skin health.

With the extended patent life of Ameluz® and the progression of its acne treatment program, Biofrontera is poised to strengthen its market presence and deliver value to both patients and shareholders in the coming years.

Delaware Court Upholds Acadia’s Patent Rights, Secures Protection for Nuplazid Formulation

by

In a significant legal victory for Acadia Pharmaceuticals Inc., a Delaware district court has ruled in favor of the company’s arguments concerning patent infringement and validity, providing crucial protection for its flagship product, Nuplazid. The ruling reinforces Acadia’s intellectual property rights and ensures continued exclusivity for the formulation of the drug, which is widely used in the treatment of Parkinson’s disease-related psychosis.

The decision, issued earlier this week by the U.S. District Court for the District of Delaware, concluded that Acadia’s patent covering the specific formulation of Nuplazid is both valid and enforceable, and that a proposed generic version would infringe on this patent. The case centered around challenges brought by a generic drug manufacturer seeking to introduce a competing product ahead of patent expiration.

Chief Executive Officer Catherine Owen Adams welcomed the ruling, stating, “This decision is a critical validation of our intellectual property strategy and our commitment to protecting innovations that bring value to patients. Patent protection for Nuplazid’s formulation is essential to ensuring we can continue investing in research and development to address unmet medical needs.”

Nuplazid, approved by the U.S. Food and Drug Administration in 2016, is known for Its unique formulation has been central to its clinical effectiveness and commercial success, making the preservation of its patent rights a top priority for Acadia.

The court’s ruling effectively blocks the launch of a generic version until the expiration of Acadia’s patent, currently set for 2030. Legal analysts noted that the decision could have broader implications for similar cases involving branded pharmaceuticals defending their market exclusivity against generic challengers.

Investors responded positively to the news, with Acadia’s shares rising in after-hours trading. The company reaffirmed its financial guidance for the year, citing confidence in the continued revenue stream from Nuplazid.

This ruling is expected to bolster confidence among stakeholders and reinforces the legal protections afforded to novel pharmaceutical formulations under U.S. patent law.

Innovative Food-Truck Design Patented by MDU’s Student Entrepreneurs and Faculty

by

In a significant achievement for innovation and entrepreneurship in academia, a group of student-entrepreneurs and faculty members from Maharshi Dayanand University (MDU), Rohtak, have been granted a patent for their novel food-truck design. The intellectual property, which blends utility with cutting-edge design features, is the brainchild of Prof. Ashish Dahiya and Sahil Saran, along with contributions from other student innovators.

According to an official statement released by the university administration today, the patented food-truck design represents a leap forward in mobile food service solutions. The design emphasizes space optimization, enhanced hygiene standards, energy efficiency, and modular functionality—key considerations for food entrepreneurs operating in urban and semi-urban environments.

“This is a proud moment for MDU. The achievement reflects the university’s focus on fostering innovation, applied research, and entrepreneurship among its students and faculty,” said a university spokesperson. “The patented design is a result of months of collaborative effort, practical experimentation, and ideation led by Prof. Dahiya and his team.”

The food truck integrates a smart layout that allows for multiple cooking stations, built-in waste management solutions, solar-powered electrical systems, and adjustable service counters. It has been engineered to cater to diverse culinary needs while ensuring compliance with safety and sanitation regulations.

Prof. Ashish Dahiya, who mentors the student entrepreneurs at MDU’s Centre for Innovation, Incubation and Entrepreneurship (CIIE), expressed gratitude for the support extended by the university administration. “This patent not only validates our design’s uniqueness and functionality but also sets a precedent for student-led innovation at MDU. We hope it inspires others to pursue real-world problem solving through interdisciplinary collaboration.”

Sahil Saran, one of the lead student inventors, highlighted the practical experiences that fueled their innovation. “We wanted to create a food truck that wasn’t just mobile but truly entrepreneurial—something that could serve as a sustainable business model for small vendors and young chefs looking to start up with minimal investment.”

The university has confirmed that efforts are underway to bring the patented design into commercial production. With potential interest from both private investors and government-supported start-up schemes, the food-truck project could soon become a real-world success story of campus innovation.

This patent adds to a growing list of intellectual property and start-up initiatives emerging from MDU in recent years, reaffirming the university’s rising stature as a hub for innovation and applied research in North India.

MU Ionic Solutions and CATL Forge Patent Licensing Agreement to Advance Lithium-Ion Battery Technologies

by

MU Ionic Solutions Corporation (MUIS), a subsidiary of Mitsubishi Chemical Corporation and UBE Corporation, has entered into a significant patent licensing agreement with Contemporary Amperex Technology Co., Limited (CATL), a global leader in energy storage and electric vehicle battery technologies. The agreement grants CATL access to MUIS’s patented lithium-ion battery (LIB) technologies, particularly in the field of electrolyte innovations.

Enhancing Battery Performance Through Collaboration

MUIS, established in 2020, focuses on the research, production, and global distribution of advanced electrolytes for lithium-ion batteries. Electrolytes are essential components that influence battery safety, performance, and lifespan. MUIS’s proprietary technology is designed to reduce side reactions within the battery, thereby improving power efficiency, extending battery life, and enhancing thermal stability.

By licensing these innovations, CATL aims to integrate MUIS’s cutting-edge electrolyte solutions into its battery systems, allowing for improvements in battery reliability, safety, and performance—particularly important for electric vehicles and renewable energy storage.

Supporting the Growing EV Market

The partnership arrives amid rapid growth in the global electric vehicle (EV) industry, where demand for high-performance, durable, and safe lithium-ion batteries continues to soar. Industry forecasts estimate a nearly 30% annual growth rate for automotive LIBs, driven by the worldwide push toward cleaner energy solutions and carbon neutrality.

Through this agreement, CATL is expected to leverage MUIS’s technologies to enhance its competitive edge in EV battery manufacturing. Meanwhile, MUIS benefits from expanded reach and validation of its proprietary electrolyte solutions in large-scale, real-world applications.

Toward a Sustainable Future

While the financial and technical details of the licensing deal remain confidential, the collaboration marks a strategic milestone for both companies. It exemplifies the power of cross-border partnerships in accelerating technological innovation and meeting the increasing global demand for sustainable energy solutions.

With MUIS’s expertise in electrolyte chemistry and CATL’s leadership in battery manufacturing, the two companies are well-positioned to contribute to the next generation of safer, more efficient lithium-ion batteries—supporting the global transition to electric mobility and renewable energy.

Apple Explores Gesture Recognition with Antenna-Based Object Detection in New Patent Application

by

The United States Patent and Trademark Office (USPTO) published a new patent application from Apple Inc. that unveils a potential leap in gesture recognition and object interaction technology for future electronic devices. The patent, titled “Electronic Devices with Antennas and VSWR Sensors for Object Detection,” outlines a system that utilizes wireless circuitry, multiple antennas, and Voltage Standing Wave Ratio (VSWR) sensors to detect the position and movement of external objects such as a user’s finger or an Apple Pencil.

The technology, according to the patent documentation, could enable Apple devices to sense the angular location and distance of objects in their vicinity, paving the way for advanced gesture control, adaptive signal direction, and more responsive device interactions — all without requiring traditional cameras or touchscreens.

The Role of VSWR Sensors in Object Detection

VSWR is a measurement typically used in antenna systems to determine impedance mismatches. In Apple’s proposed design, however, VSWR readings are repurposed for spatial sensing. The system measures how signals reflect off nearby objects, with changes in the reflected wave patterns offering clues about the object’s distance and angle relative to the device’s antennas.

By deploying multiple antennas at strategic locations on a device, each equipped with VSWR sensors, the device’s onboard processors can triangulate the position of external elements. For instance, if a user’s finger approaches the side of a tablet or an Apple Pencil hovers above a display, the system can detect this and respond appropriately.

Enhanced Communication and Gesture Recognition

One of the key innovations described in the patent is the device’s ability to adapt its wireless communication dynamically based on the location of nearby objects. If a user’s hand is found to be obstructing the optimal path for signal transmission, the device can automatically adjust beamforming directions or signal power to maintain performance.

More notably, the system opens new possibilities for gesture-based controls. Without relying on cameras or external sensors, a device could recognize finger movements or stylus gestures in the air, offering new ways to navigate interfaces, trigger shortcuts, or interact with content.

Apple suggests that this technology could be integrated into a range of future products, including smartphones, tablets, wearables, and even smart glasses or other head-mounted displays.

Potential Use Cases

The application hints at a number of forward-looking applications for the technology, including:

  • Air-based gestures: Users could control volume, scroll through documents, or launch applications with mid-air swipes or circular motions near the device.
  • Smart Pencil tracking: Apple Pencil movements could be detected even when not in contact with a screen, improving handwriting and drawing precision or enabling 3D input.
  • Adaptive signal optimization: Devices could identify hand positions during use and redirect antennas for better network or accessory connections.

Future Implications

This patent aligns with Apple’s growing interest in spatial computing and non-contact interaction technologies. With products like the Vision Pro and advancements in LiDAR and ultra-wideband (UWB) sensors, Apple continues to push the envelope in how users interact with digital content and hardware.

While not all patents lead directly to commercial products, this filing reinforces Apple’s direction toward intuitive, touch-free user interfaces. It could ultimately influence the next generation of iPads, iPhones, and wearables, further blurring the line between the physical and digital worlds.

As with many of Apple’s patent applications, the timing and implementation of this technology remain uncertain. However, its publication offers a clear glimpse into the company’s ambitions for smarter, more context-aware devices that respond seamlessly to their users’ presence and intent.

Maruti Suzuki e-Vitara Patented in India; Launch Scheduled for September 2025

by
Maruti Suzuki has officially patented its upcoming electric SUV, the e-Vitara, in India, marking a significant step towards its anticipated launch in September 2025. This move positions Maruti Suzuki to compete in the rapidly expanding electric vehicle (EV) market in India.

Design and Platform
The e-Vitara is built on the Heartect-e platform, a collaboration between Suzuki and Toyota. This platform integrates eAxles, combining the motor and inverter into a single unit, enhancing efficiency and performance. The SUV features a rugged design with elements like 3-point Matrix LED DRLs, rear lamps, 18-inch alloy wheels, and active air vents at the front to improve aerodynamics .

Battery Options and Range
Maruti Suzuki offers two battery pack options, the larger 61 kWh battery is expected to provide a range of over 500 km on a single charge, making it competitive in its segment .

Interior Features
Inside, the e-Vitara boasts a modern cabin with a 10.25-inch instrument cluster, ambient lighting, a floating center console, a wireless charging pad, and a panoramic glass roof. The SUV also offers a 10-way electrically adjustable driver’s seat and a 40:20:40 split rear seat configuration, enhancing comfort and practicality .

Safety and Technology
Safety features include seven airbags as standard across all variants, a 360-degree camera, and a suite of Advanced Driver Assistance Systems (ADAS). These features aim to provide a high level of safety for occupants .

Pricing and Launch Details
The e-Vitara is expected to be priced competitively, with the base 49 kWh variant starting around ₹20 lakh (ex-showroom). The 61 kWh variant could be priced at approximately ₹25 lakh, while the AllGrip-e AWD model may approach ₹30 lakh . Production is set to commence at Maruti’s Gujarat plant, with exports planned to over 100 countries, including Europe and Japan .


Competitors in the Indian Market
Upon launch, the Maruti Suzuki e-Vitara will compete against several established and upcoming electric SUVs in India, including:

Tata Curvv EV: Expected to be priced between ₹17.49 lakh and ₹22.24 lakh .

Mahindra BE 6: Priced at ₹18.90 lakh .

Hyundai Creta Electric: Expected to be priced between ₹17.99 lakh and ₹24.38 lakh .

MG ZS EV: Priced between ₹18.98 lakh and ₹26.64 lakh .

With its competitive pricing, advanced features, and robust performance, the Maruti Suzuki e-Vitara is poised to be a strong contender in the Indian electric SUV market.